Health Minister reviews supply and availability of COVID related essential medicines and their buffer stocks in country

Union Minister for Health and Family Welfare Mansukh Mandaviya on Wednesday reviewed the supply and availability of COVID-19 related essential medicines and their buffer stocks in the country. During the review meeting, it was noted that sufficient stocks of all the essential medicines are available. Raw materials for these drugs are also available in enough quantities. The government has created a strategic buffer stock for 8 drugs and all of these are available in the country. These drugs are Tocilizumab, Methyl Prednisolone, Enaxopirin, Dexamethasone,  Remdesivir, Amphotericin B Deoxycholate, Posaconazole and Intravenous Immunoglobulin.


The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies